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Rare diseases are very complex and require comprehensive
strategic planning. Because health and social services were
not well adapted to the needs of those most vulnerable
patients, a first National Plan for Rare Diseases has been
implemented in France between 2009 and 2010, acknowl-
edging the specificities of rare diseases. Information was
developed for patients, professionals and the general pub-
lic (in Orphanet database and Maladies Rares Info Service
helpline), access to high quality care and treatment was
facilitated with the designation of 131 centres of reference
at National level, and 502 centres of competence at regio-
nal level, and the coordination and funding of research
was improved, with a 200 million Euros budget overall.
After a thorough evaluation, the second French Plan
consolidates previous achievements, and reinforces
European and international cooperation. The aim is to
diagnose and cover each and every disease and patient.
20 university laboratories of genetics have been equipped
with Next Generation Sequencing technology for clinical
use. Research, public health and social authorities, health
agencies, patients associations, experts, scientific societies
are working together to improve the evaluation of the cen-
ters of expertise and regroup them into 20 to 30 networks,
to be further integrated in European reference networks.
Centers coordinate diagnosis, provision of health and
social care, training, they write National Protocols for
Diagnosis and Care, collect data, conduct clinical trials.
A Foundation for research on rare diseases including a
National data bank has been created.
Thanks to the work of patient organizations and
health professionals raising awareness about rare dis-
eases, to a close and exemplary collaboration between
them and public authorities, the 3 axes, 15 measures,
47 actions, and more than 200 Millions € budget of the
Second Plan set up rare diseases as a model for struc-
turing health care provision and research, as well as a
model for a tolerant society and an open democracy:
8000 rare diseases, an exemplary model.
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